Prognostic Factors Influencing Infectious Complications after Cytoreductive Surgery and HIPEC: Results from a Tertiary Referral Center
- PMID: 31191642
- PMCID: PMC6525932
- DOI: 10.1155/2019/2824073
Prognostic Factors Influencing Infectious Complications after Cytoreductive Surgery and HIPEC: Results from a Tertiary Referral Center
Abstract
Background: Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) showed promising results in selected patients. High morbidity restrains its wide application. The aim of this study was to report postoperative infectious complications and investigate possible correlations with the preoperative nutritional status and other prognostic factors in patients with peritoneal metastases treated with CRS and HIPEC.
Methods: For the study, we reviewed the clinical records of all patients with peritoneal metastases from different primary cancers treated with CRS and HIPEC in our Institution from November 2000 to December 2017. Patients were divided according to their nutritional status (SGA) into groups A (well-nourished) and B/C (mild or severely malnourished, respectively). Possible statistical correlations between risk factors and postoperative complication rates have been investigated by univariate and multivariate analysis.
Results: Two hundred patients were selected and underwent CRS and HIPEC during the study period. Postoperative complications occurred in 44% of the patients, 35.3% in SGA-A patients, and 53% in SGA-B/C patients. Cause of complications was infective in 42, noninfective in 37, and HIPEC related in 9 patients. Infectious complications occurred more frequently in SGA-B/C patients (32.6% vs. 9.8% of SGA-A patients). The most frequent sites of infection were surgical site infections (SSI, 35.7%) and central line-associated bloodstream infections (CLABSI, 26.2%). The most frequent isolated species was Candida (22.8%). ASA score, blood loss, performance status, PCI, large bowel resection, postoperative serum albumin levels, and nutritional status correlated with higher risk for postoperative infectious complications.
Conclusions: Malnourished patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy are more prone to postoperative infectious complications, and adequate perioperative nutritional support should be considered, including immune-enhancing nutrition. Sequential monitoring of common sites of infection, antifungal prevention of candidiasis, and careful patient selection should be implemented to reduce the complication rate.
Similar articles
-
The relationship between baseline nutritional status with subsequent parenteral nutrition and clinical outcomes in cancer patients undergoing hyperthermic intraperitoneal chemotherapy.Nutr J. 2013 Aug 14;12:118. doi: 10.1186/1475-2891-12-118. Nutr J. 2013. PMID: 23941331 Free PMC article.
-
Preoperative Nutrition Status and Postoperative Outcomes in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.Ann Surg Oncol. 2019 Aug;26(8):2622-2630. doi: 10.1245/s10434-019-07415-7. Epub 2019 May 23. Ann Surg Oncol. 2019. PMID: 31123932
-
[Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Mar 25;24(3):230-239. doi: 10.3760/cma.j.cn.441530-20201110-00603. Zhonghua Wei Chang Wai Ke Za Zhi. 2021. PMID: 34645167 Chinese.
-
Peritoneal cancer index (PCI) based patient selecting strategy for complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis: A single-center retrospective analysis of 125 patients.Eur J Surg Oncol. 2021 Jun;47(6):1411-1419. doi: 10.1016/j.ejso.2020.11.139. Epub 2020 Dec 1. Eur J Surg Oncol. 2021. PMID: 33293213
-
Pelvic exenteration, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancy: experience and outcomes from an exenterative and peritonectomy unit.Langenbecks Arch Surg. 2021 Dec;406(8):2807-2815. doi: 10.1007/s00423-021-02323-5. Epub 2021 Sep 8. Langenbecks Arch Surg. 2021. PMID: 34495403 Review.
Cited by
-
Risk factors for postoperative complications in patients undergoing cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: A meta-analysis and systematic review.Int J Colorectal Dis. 2024 Oct 18;39(1):167. doi: 10.1007/s00384-024-04741-5. Int J Colorectal Dis. 2024. PMID: 39422815 Free PMC article.
-
The relationship between baseline nutritional status with subsequent parenteral nutrition and clinical outcomes in cancer patients undergoing cytoreductive surgery: a retrospective study.Front Nutr. 2024 May 3;11:1364959. doi: 10.3389/fnut.2024.1364959. eCollection 2024. Front Nutr. 2024. PMID: 38765813 Free PMC article.
-
The impact of hyperthermic intraperitoneal chemotherapy and cytoreductive surgery on clinical outcomes and quality of life of patients with peritoneal carcinomatosis.Contemp Oncol (Pozn). 2021;25(4):270-278. doi: 10.5114/wo.2021.112038. Epub 2021 Dec 29. Contemp Oncol (Pozn). 2021. PMID: 35079235 Free PMC article.
-
Challenges following CRS and HIPEC surgery in cancer patients with peritoneal metastasis: a comprehensive review of clinical outcomes.Front Surg. 2024 Dec 2;11:1498529. doi: 10.3389/fsurg.2024.1498529. eCollection 2024. Front Surg. 2024. PMID: 39687325 Free PMC article. Review.
-
Etiological analysis of infection after CRS + HIPEC in patients with PMP.BMC Cancer. 2023 Sep 26;23(1):903. doi: 10.1186/s12885-023-11404-1. BMC Cancer. 2023. PMID: 37752468 Free PMC article.
References
-
- Capone A., Valle M., Proietti F., Federici O., Garofalo A., Petrosillo N. Postoperative infections in cytoreductive surgery with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis. Journal of Surgical Oncology. 2007;96(6):507–513. doi: 10.1002/jso.20837. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous